Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence.
Macrophages infected with attenuated Mycobacterium tuberculosis strain H37Ra become apoptotic, which limits bacterial replication and facilitates antigen presentation. Here we demonstrate that cells infected with H37Ra became apoptotic after the formation of an apoptotic envelope on their surface was complete. This process required exposure of phosphatidylserine on the cell surface, followed by deposition of the phospholipid-binding protein annexin-1 and then transglutaminase-mediated crosslinking of annexin-1 through its amino-terminal domain. In macrophages infected with the virulent strain H37Rv, in contrast, the amino-terminal domain of annexin-1 was removed by proteolysis, thus preventing completion of the apoptotic envelope, which resulted in macrophage death by necrosis. Virulent M. tuberculosis therefore avoids the host defense system by blocking formation of the apoptotic envelope, which leads to macrophage necrosis and dissemination of infection in the lung.
Gan
Huixian
H
Brigham & Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Lee
Jinhee
J
Ren
Fucheng
F
Chen
Minjian
M
Kornfeld
Hardy
H
Remold
Heinz G
HG
D000818:Animals; D017302:Annexins / Q000276:immunology / Q000378:metabolism*; D017209:Apoptosis / Q000276:immunology*; D006801:Humans; D015151:Immunoblotting; D008264:Macrophages / Q000276:immunology / Q000382:microbiology*; D008565:Membrane Proteins; D051379:Mice; D008807:Mice, Inbred BALB C; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000472:pathogenicity*; D009336:Necrosis / Q000276:immunology; D017396:Plasminogen Activator Inhibitor 2 / Q000276:immunology / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014376:Tuberculosis / Q000276:immunology*; D014774:Virulence
D017302:Annexins; D008565:Membrane Proteins; D017396:Plasminogen Activator Inhibitor 2; D012333:RNA, Messenger
J Biol Chem. 1991 Jan 15;266(2):1101-8
1670773
Annu Rev Cell Dev Biol. 2004;20:367-94
15473845
J Immunol. 2006 Apr 1;176(7):4267-74
16547264
Infect Immun. 2003 Apr;71(4):1763-73
12654790
Biochem Biophys Res Commun. 1989 Sep 15;163(2):944-51
2571332
Cancer Res. 1990 Jan 1;50(1):120-8
1967140
J Clin Invest. 2001 Oct;108(7):957-62
11581295
Eur J Cell Biol. 1993 Feb;60(1):210-6
8096461
J Hepatol. 2001 Sep;35(3):367-75
11592598
Immunity. 2006 Jan;24(1):105-17
16413927
J Immunol. 2007 Aug 15;179(4):2509-19
17675513
J Clin Invest. 2005 Jun;115(6):1601-6
15931391
J Struct Biol. 2001 Jan;133(1):55-63
11356064
Blood. 1995 Dec 1;86(11):4007-24
7492756
Tuberculosis (Edinb). 2002;82(2-3):55-61
12356455
J Biol Chem. 1986 Aug 25;261(24):11207-13
3090045
J Biol Chem. 1995 Jul 28;270(30):17702-11
7543090
J Immunol. 2003 Jan 1;170(1):430-7
12496428
Cell Death Differ. 1998 Feb;5(2):163-71
10200461
J Exp Med. 1984 Jun 1;159(6):1653-68
6374011
Eur J Biochem. 1993 May 15;214(1):141-6
8099547
J Biol Chem. 1994 May 27;269(21):15394-8
7910824
Nature. 2005 Apr 7;434(7034):767-72
15815631
J Biol Chem. 1992 Apr 5;267(10):7089-94
1551915
Dev Cell. 2003 Apr;4(4):587-98
12689596
J Biol Chem. 1987 May 15;262(14):6931-7
2952659
Am J Pathol. 2001 Feb;158(2):603-15
11159197
J Immunol. 1998 Jun 1;160(11):5448-54
9605147
J Immunol. 2001 Apr 1;166(7):4604-11
11254718
Exp Cell Res. 2000 Apr 10;256(1):42-9
10739650
Science. 2007 Jan 26;315(5811):509-13
17255510
J Leukoc Biol. 1999 Jul;66(1):172-82
10411006
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Am J Respir Cell Mol Biol. 2003 Nov;29(5):545-51
12748057
Nat Med. 2003 Aug;9(8):1039-46
12872166
J Infect Dis. 2004 Sep 15;190(6):1167-76
15319868
Cell Death Differ. 2001 Feb;8(2):113-26
11313713
Cell Mol Life Sci. 2004 Feb;61(3):301-25
14770295
J Biol Chem. 1997 May 2;272(18):12035-46
9115270
J Immunol. 1995 Aug 1;155(3):1304-15
7636197
Infect Immun. 1997 Jan;65(1):298-304
8975927
Infect Immun. 2003 Jan;71(1):254-9
12496173
J Immunol. 1997 May 1;158(9):4320-7
9126994
Annu Rev Physiol. 1998;60:619-42
9558479
J Immunol. 2003 Mar 1;170(5):2409-16
12594264
Nat Rev Mol Cell Biol. 2005 Jun;6(6):449-61
15928709
J Immunol. 2006 Mar 15;176(6):3707-16
16517739
J Biol Chem. 1991 Aug 15;266(23):15240-3
1714455
J Leukoc Biol. 2006 Jan;79(1):80-6
16275894
J Cell Sci. 1998 May;111 ( Pt 10):1405-18
9570758
Exp Cell Res. 1995 Mar;217(1):65-71
7867722
Biochemistry. 1978 Jun 27;17(13):2598-604
28146
J Immunol. 2000 Feb 15;164(4):2016-20
10657653
Nat Immunol. 2001 Jul;2(7):612-9
11429545
J Immunol. 2001 Jun 15;166(12):7128-35
11390458
J Biol Chem. 1995 Nov 17;270(46):27894-904
7499264
J Immunol. 1998 Sep 1;161(5):2636-41
9725266
J Biol Chem. 2003 Dec 19;278(51):51613-21
14532286